Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens

Cytomegalovirus (CMV) reactivation during chemotherapy or after organ or hematopoietic stem cell transplantation is a major cause of morbidity and mortality, and the risk of reactivation increases with patients’ age. Bendamustine, an alkylating agent currently used for treatment of indolent and aggr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pezzullo, Luca, Giudice, Valentina, Serio, Bianca, Fontana, Raffaele, Guariglia, Roberto, Martorelli, Maria Carmen, Ferrara, Idalucia, Mettivier, Laura, Bruno, Alessandro, Bianco, Rosario, Vaccaro, Emilia, Pagliano, Pasquale, Montuori, Nunzia, Filippelli, Amelia, Selleri, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082049/
https://www.ncbi.nlm.nih.gov/pubmed/33981851
http://dx.doi.org/10.1515/med-2021-0274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082049/
https://www.ncbi.nlm.nih.gov/pubmed/33981851
http://dx.doi.org/10.1515/med-2021-0274

Ejemplares similares